Viewing Study NCT05777148



Ignite Creation Date: 2024-05-06 @ 6:46 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05777148
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-03-21
First Post: 2023-03-08

Brief Title: Comparison of Efficacy in Removal of Advanced Glycation End Products AGEs Between Super High-flux Hemodialysis and Postdilution Online Hemodiafiltration A Single-center Prospective Open-label Crossover Randomized Controlled Trial
Sponsor: Mahidol University
Organization: Mahidol University

Study Overview

Official Title: Comparison of Efficacy in Removal of Advanced Glycation End Products AGEs Between Super High-flux Hemodialysis and Postdilution Online Hemodiafiltration A Single-center Prospective Open-label Crossover Randomized Controlled Trial
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2023-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to compare efficacy in advanced glycation end products removal between Super high-flux Hemodialysis and high-volume post-dilution online hemodiafiltration The main question it aims to answer are

Efficacy endothelial dysfunction biomarker AGEs in super high-flux hemodialysis compared to online HDF
Safety profile Dialysate albumin loss Intradialytic complication

Participants will be asked to randomized in 2 groups Super high-flux HD or post dilution ol-HDF Researchers will compare SHF-HD and ol-HDF to see whether SHF-HD could remove AGEs better than ol-HDF
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None